You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of news articles, starting from most recent.

• Pages
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

• • Jul 29, 2010
  • AstraZeneca PLC second quarter and half year results 2010  
• • Jul 28, 2010
  • FDA Advisory Committee recommends US FDA approval of BRILINTA (ticagrelor) for Acute Coronary Syndromes  
• • Jul 21, 2010
  • AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. provide medicines to Missouri’s uninsured  
• • Jul 20, 2010
  • National contest encourages people with depressive symptoms of bipolar disorder or major depressive disorder to speak out  
• • Jul 1, 2010
  • ARIMIDEX® (anastrozole) Tablets Savings Card provides instant savings to eligible patients  
• • Jun 29, 2010
  • CRESTOR® patent upheld by US Court  
• • Jun 26, 2010
  • Dapagliflozin as add on therapy to insulin demonstrated improved glycemic control in patients with type 2 diabetes inadequately controlled with insulin  
• • Jun 26, 2010
  • 52-week study finds ONGLYZA™ (saxagliptin) when added to metformin was non-inferior to titrated glipizide when added to metformin in reducing glycosylated hemoglobin (HbA1c) in adults with type 2 diabetes mellitus  
• • Jun 26, 2010
  • ONGLYZA™ (saxagliptin) with metformin as initial combination therapy provided 76-week long-term glycemic control in treatment-naïve adults with type 2 diabetes  
• • Jun 23, 2010
  • AstraZeneca and Targacept initiate Phase 3 clinical development of TC-5214 as an adjunct treatment for major depressive disorder  

• Pages
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed